Archive
A tighter archive for life-science signals.
Search once, then narrow by source or topic.
Roche's Gazyva, on an autoimmune hot streak, looks to further its new foothold in lupus with phase 3 win - Fierce Pharma
Roche's Gazyva, on an autoimmune hot streak, looks to further its new foothold in lupus with phase 3 win Fierce Pharma
Roche contends with loss of momentum for key medicines, currency fluctuations in Q3 but keeps growth on track - Fierce Pharma
Roche contends with loss of momentum for key medicines, currency fluctuations in Q3 but keeps growth on track Fierce Pharma
Roche follows peers with $50B investment in US manufacturing, research sites - FirstWord Pharma
Roche follows peers with $50B investment in US manufacturing, research sites FirstWord Pharma